Nexcare Bandages partners with America’s Blood Centers
ST. PAUL, Minn. Nexcare Bandages announced earlier this month that it will partner with America’s Blood Centers on a new initiative to make blood donation a national priority by thanking donors and encouraging recurring donations.
Nexcare Bandages and America’s Blood Centers will salute blood donors with a limited edition “give” bandage, created by Nexcare, which will be distributed at blood centers nationwide June 8 through 14.
“We are passionate about this noble cause and committed to raising awareness and recognition in our communities,” stated Paul Hansen, division general manager, 3M Consumer Health Care. “The dedication of blood donors across the country is inspiring — these people are saving lives every day. We hope donors will wear their Nexcare “give” bandages with pride to show that they have donated blood and encourage others to do the same.”
In addition to use at blood centers nationwide, free samples of the Nexcare “give” bandages will be available to the public beginning May 1 ww.nexcare.com/give.
“We are grateful to all donors for their lifesaving work,” commented Don Doddridge, president of America’s Blood Centers. “With the economy in flux, we encourageAmericans to remember there are many ways to give back. If you consider that just one hour of your time is enough to save three lives, giving blood regularly is a great way for volunteers to serve their community.”
Study finds that Mannatech supplement can improve vision, memory
COPPELL, Texas One tablespoon of a dietary supplement can improve mental functioning, a study indicates.
The study, by researchers at Howard University and published in the journal Perceptual & Motor Skills, indicated that a tablespoon of Mannatech’s supplement Ambrotose can “significantly improve” visual discrimination and working memory.
“The results of this study are impressive because they show significant improvement in the perceptual capabilities of healthy adults, which indicates that Ambrotose complex can benefit everyone,” researcher Atiya Stancil said.
Stancil and fellow researcher Leslie Hicks conducted the randomized, double-blind, placebo-controlled study on 62 healthy young adults.
WellSpring’s anti-nausea medication proves successful in market
SARASOTA, Fla, WellSpring Pharmaceutical on Tuesday announced that its anti-nausea liquid Emetrol is now the leading product in its category based on trailing 52-week sales ended Jan. 14, citing data from Information Resources Inc.
Over that 52-week period, Emetrol marketshare grew to 51.7% of the category based on sales growth of more than 24%.
WellSpring recently rolled out a national advertising campaign targeting women between the ages of 25 and 34, the company stated. And the National Association of Pediatric Nurse Practitioners recently selected Emetrol for editorial content in an upcoming issue.
“The fact that we are recommended by OB/GYN physicians for their patients experiencing nausea associated with pregnancy and by pediatricians for children under their care, has proven to be one of the most important attributes of the brand,” stated WellSpring president and CEO Robert Vukovich.